Canadian drug makers are facing a $1.1-billion lawsuit for their role in the opioid crisis. A proposed class action filed Wednesday accuses almost two dozen companies of enriching themselves at the expense of vulnerable patients.
from CBC | Health News http://bit.ly/30o8sNN
Aucun commentaire:
Enregistrer un commentaire